Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells

[1]  Sanjeev Banerjee,et al.  Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein. , 2007, Cancer research.

[2]  F. Ciardiello,et al.  Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer , 2007, Oncogene.

[3]  D. Neri,et al.  The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis. , 2007, Cancer research.

[4]  Jing-Yuan Fang,et al.  Inhibition of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells* , 2007, Journal of Biological Chemistry.

[5]  S. Brand,et al.  Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease , 2007, Gut.

[6]  Didier Merlin,et al.  Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. , 2007, Cancer research.

[7]  Y. Miyagi,et al.  Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. , 2007, Cancer research.

[8]  R Nyga,et al.  The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation , 2007, Oncogene.

[9]  C. Pecquet,et al.  Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. , 2007, Blood.

[10]  H. Allgayer,et al.  Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer , 2007, Clinical Cancer Research.

[11]  D. Frank,et al.  STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas , 2007, Oncogene.

[12]  G. Milano,et al.  JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. , 2006, European journal of cancer.

[13]  Sheung Tat Fan,et al.  Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. , 2006, Cancer research.

[14]  S. Curran,et al.  Profiling markers of prognosis in colorectal cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  E. Gehan,et al.  Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence , 2005, Clinical Cancer Research.

[16]  P. Dent,et al.  Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. , 2005, Molecular cancer therapeutics.

[17]  Guoqiang Chen,et al.  AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Clevenger.  Roles and regulation of stat family transcription factors in human breast cancer. , 2004, The American journal of pathology.

[19]  Lothar Schweigerer,et al.  Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas , 2004, Cancer Research.

[20]  J. Grandis,et al.  Constitutive activation of Stat5b contributes to carcinogenesis in vivo. , 2003, Cancer research.

[21]  M. LeBaron,et al.  Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells* , 2003, Journal of Biological Chemistry.

[22]  Hans C Clevers,et al.  Molecular causes of colon cancer , 2002, European journal of clinical investigation.

[23]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[24]  S. Fan,et al.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.

[25]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[26]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[27]  P. Coffer,et al.  The role of STATs in myeloid differentiation and leukemia , 2000, Oncogene.

[28]  S. Nagata,et al.  Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Jove,et al.  STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription. , 1999, Current opinion in oncology.